BakerHostetler
Biological markers for identifying patients for treatment with abiraterone acetate
Provided herein are methods of predicting a likelihood of survival following treatment with AA and prednisone in a patient having CRPC.
Janssen Pharmaceutica NV
C C A A C C
C12Q C12Q A61K A61K C12Q C12Q
additional inventional inventional inventional additional inventional
Michael Weimin Michael Deborah Jayaprakash
Gormley Li Schaffer Sokol Ricci Karkera